Stapled Peptide Design Group

The Stapled Peptide Design Group specializes in the design, synthesis, and application of stapled alpha-helical peptides for cancer research. We provide services to multiple research groups in the Dana-Farber community - including the Linde Program in Cancer Chemical Biology, Department of Pediatric Oncology, and Department of Cancer Biology - as well as laboratories outside the Institute. We are pleased to participate in academic collaborations by designing and generating stapled peptides for your cancer research needs. Our goal is to remain fully engaged with our collaborators to provide ongoing input on experimental design, data analysis, and project development. Submit your project proposals by email to Greg Bird (greg_bird@dfci.harvard.edu)

PERSONNEL

Greg Bird, PhD
Senior Scientist

Dr. Bird is a Senior Scientist in the Walensky Laboratory at the Dana-Farber Cancer Institute. He received his BS and PhD degrees in Chemistry from the University of Pittsburgh in 1999 and 2006, respectively. Dr. Bird’s graduate studies were mentored by Chris Schafmeister, PhD, and focused on the development of a universal molecular scaffold to facilitate the design, construction, and analysis of macromolecules that orient functionality in three-dimensional space. He joined the Walensky laboratory as a Postdoctoral Fellow in 2006 and was promoted to Senior Scientist in 2012. Dr. Bird has advanced the peptide stapling technology to a diversity of in vivo applications in cancer, infectious disease, and metabolism.

Marina Godes
Senior Research Technician
Tun Oo
Research Technician